Organisation paid for research Program year 2025 Source: CMS Open Payments

Frontier Clinical Research

Neither a doctor nor a teaching hospital

Research payments

$2,580,456

218 payments

Through program year 2025, Frontier Clinical Research is reported as receiving $2,580,456 in research payments, across 218 payments.

By program year

7 rows

Year	Kind	Amount	Payments
2025	Research	$348,900	37
2024	Research	$571,517	50
2023	Research	$1,092,832	43
2022	Research	$419,161	20
2021	Research	$40,232	55
2020	Research	$65,791	7
2019	Research	$42,023	6

Breakdown

Who paid Research payments · program years 2019–2025

Pfizer Inc. $806,149 42 payments
Cue Health Inc. $518,480 3 payments
Roche Molecular Systems, Inc. $443,888 59 payments
Genentech, Inc. $416,053 14 payments
OraSure Technologies Inc. $236,750 21 payments
H. Lundbeck A S $72,269 10 payments
Hikma Pharmaceuticals USA $40,854 6 payments
Boehringer Ingelheim Canada Ltd.Ltee $30,253 49 payments
AbbVie, Inc. $11,090 11 payments
Boehringer Ingelheim Pharmaceuticals, Inc. $2,470 2 payments

Studies the money was for Research payments · program years 2019–2025

A Phase 3 Randomized Placebocontrolled Observerblinded Trial to Evaluate the Safety of A 6Valent Ospabased Lyme Disease Vaccine Vla15 in Healthy Children 5 Through 17 Years of Age $804,870 41 payments
RSV, Influenza $517,260 1 payment
Transmission Study Household $416,053 14 payments
Rd006493 $297,605 27 payments
Human Factors and Clinical Validation of the Orasure InteliSwab COVID-19+Flu A&B Rapid Test in Anterior Nasal Samples For Over-the-Counter (OTC) Use $218,050 10 payments
Rd006702 $141,402 28 payments
Evaluate Efficacy & Safety of Eptinezumab Administered Intravenously in Subjects Experiencing Acute Attack of Migraine (RELIEF) $39,473 3 payments
A Parallel Group, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Eptinezumab Administered Intravenously in Subjects Experiencing An Acute Attack of Migraine $32,797 7 payments
BI 767551 (EX14870) Ph II/III SARS-COV-2 Ambulatory Pts IV $30,253 49 payments
Clinical Sample Collection and Testing Protocol $18,700 11 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.